BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38432938)

  • 1. [Chemical Design of Radiohalogenated Agents Using Neopentyl Structure].
    Uehara T
    Yakugaku Zasshi; 2024; 144(3):285-290. PubMed ID: 38432938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High
    Suzuki H; Kaizuka Y; Tatsuta M; Tanaka H; Washiya N; Shirakami Y; Ooe K; Toyoshima A; Watabe T; Teramoto T; Sasaki I; Watanabe S; Ishioka NS; Hatazawa J; Uehara T; Arano Y
    J Med Chem; 2021 Nov; 64(21):15846-15857. PubMed ID: 34708646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting peptides and positron emission tomography.
    Lundqvist H; Tolmachev V
    Biopolymers; 2002; 66(6):381-92. PubMed ID: 12658725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo stable
    Suzuki H; Kannaka K; Hirayama M; Yamashita T; Kaizuka Y; Kobayashi R; Yasuda T; Takahashi K; Uehara T
    EJNMMI Radiopharm Chem; 2024 Jun; 9(1):48. PubMed ID: 38884866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labeling monoclonal antibodies with halogen nuclides.
    Zalutsky MR; Garg PK; Narula AS
    Acta Radiol Suppl; 1990; 374():141-5. PubMed ID: 1966962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
    Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
    J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor gamma ligands: potential positron emission tomography and single photon emission computed tomography imaging agents.
    Lee BC; Lee KC; Lee H; Mach RH; Katzenellenbogen JA
    Bioconjug Chem; 2007; 18(2):514-23. PubMed ID: 17315977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiopharmaceutical chemistry with iodine-124: a non-standard radiohalogen for positron emission tomography.
    Chacko AM; Divgi CR
    Med Chem; 2011 Sep; 7(5):395-412. PubMed ID: 21711220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-(
    Sasaki I; Tada M; Liu Z; Tatsuta M; Okura T; Aoki M; Takahashi K; Ishioka NS; Watanabe S; Tanaka H
    Org Biomol Chem; 2023 Sep; 21(36):7467-7472. PubMed ID: 37670575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of
    Tago T; Toyohara J; Fujimaki R; Tatsuta M; Song R; Hirano K; Iwai K; Tanaka H
    Nucl Med Biol; 2021; 94-95():38-45. PubMed ID: 33493787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiohalogen-labeled imaging agents. 3. Compounds for measurement of brain blood flow by emission tomography.
    Sargent T; Shulgin AT; Mathis CA
    J Med Chem; 1984 Aug; 27(8):1071-7. PubMed ID: 6611416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetry.
    Orlova A; Höglund J; Lubberink M; Lebeda O; Gedda L; Lundqvist H; Tolmachev V; Sundin A
    Cancer Biother Radiopharm; 2002 Aug; 17(4):385-96. PubMed ID: 12396703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The next generation of positron emission tomography radiopharmaceuticals in oncology.
    Rice SL; Roney CA; Daumar P; Lewis JS
    Semin Nucl Med; 2011 Jul; 41(4):265-82. PubMed ID: 21624561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Chemistry of Astatine and Implications for the Development of Radiopharmaceuticals.
    Guérard F; Maingueneau C; Liu L; Eychenne R; Gestin JF; Montavon G; Galland N
    Acc Chem Res; 2021 Aug; ():. PubMed ID: 34350753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
    Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
    Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.
    Maisonial A; Kuhnast B; Papon J; Boisgard R; Bayle M; Vidal A; Auzeloux P; Rbah L; Bonnet-Duquennoy M; Miot-Noirault E; Galmier MJ; Borel M; Askienazy S; Dollé F; Tavitian B; Madelmont JC; Moins N; Chezal JM
    J Med Chem; 2011 Apr; 54(8):2745-66. PubMed ID: 21417462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques.
    Yang Y; Zhang X; Cui M; Zhang J; Guo Z; Li Y; Zhang X; Dai J; Liu B
    Sci Rep; 2015 Jul; 5():12084. PubMed ID: 26170205
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.